# ONCOLYTICS BIOTECH INC (ONCY)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/ONCY/

- Reporting holders: 4
- Reported value: $164.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Everhart Financial Group, Inc.](https://holderbook.com/funds/1852858-everhart-financial-group-inc/) | $95.1K | 142,341 | 0.0% | 2 |
| [DOLIVER ADVISORS, LP](https://holderbook.com/funds/938077-doliver-advisors-lp/) | $66.8K | 100,000 | 0.0% | 2 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $2.0K | 3,023 | 0.0% | 2 |
| [PROFESSIONAL ADVISORY SERVICES INC](https://holderbook.com/funds/894205-professional-advisory-services-inc/) | $20 | 30,000 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 4 | $164.0K |
| Q2 2026 | 78 | $3.8M |
| Q1 2026 | 59 | $3.3M |
| Q4 2025 | 61 | $2.4M |
| Q3 2025 | 56 | $3.8M |
| Q2 2025 | 55 | $1.2M |
| Q1 2025 | 51 | $755.8K |
| Q4 2024 | 46 | $1.2M |
| Q3 2024 | 41 | $899.2K |
| Q2 2024 | 41 | $1.3M |
| Q1 2024 | 36 | $2.3M |
| Q4 2023 | 44 | $7.3M |